(Q33365567)

26 July 2017

Argatroban for anticoagulation during cardiopulmonary bypass in an infant (English)

1 reference

26 July 2017

1 reference

Peter C Dyke

1

1 reference

26 July 2017

Pierantonio Russo

2

1 reference

26 July 2017

Leila Mureebe

3

1 reference

26 July 2017

Joanne Russo

4

1 reference

26 July 2017

Joseph D Tobias

5

1 reference

26 July 2017

1 April 2005

1 reference

26 July 2017

Paediatric Anaesthesia

1 reference

26 July 2017

15

1 reference

26 July 2017

4

1 reference

26 July 2017

328-333

1 reference

Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

A synopsis of the clinical uses of argatroban

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Hirudin in heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Argatroban use during pediatric interventional cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Argatroban During Percutaneous Transluminal Coronary Angioplasty: Results of a Dose-Verification Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Pharmacologic preservation of the hemostatic system during cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Pharmacology of recombinant hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Hirudin in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Methods for the monitoring of direct thrombin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2005.01417.X

10.1111/J.1460-9592.2005.01417.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference